The Novartis Board of Directors is responsible for the direction, strategy, organization and administration of the company. The Board comprises 12 members with Giovanni Caforio as chair.

Download the Board of Director Committee Organizational Chart (PDF 0.1 MB)

Giovanni Caforio, M.D., Board chair
Giovanni Caforio, M.D.
Chair since 2025
Simon Moroney, D.Phil., Board vice-chair
Simon Moroney, D.Phil.
Board member since 2020 | Vice-Chair since 2022
Nancy C. Andrews, M.D., Ph.D., Board member
Nancy C. Andrews, M.D., Ph.D.
Board member since 2015
Ton Buechner, Board member
Ton Buechner
Board member since 2016
Patrice Bula, Board member
Patrice Bula
Board member since 2019 | Lead Independent Director since 2022
Elizabeth (Liz) Doherty, Board member
Elizabeth (Liz) Doherty
Board member since 2016
Bridgette Heller, Board member
Bridgette Heller
Board member since 2020
Daniel Hoschstrasser, Board member
Daniel Hochstrasser
Board member since 2022
Frans van Houten, Board member
Frans van Houten
Board member since 2017
Elizabeth McNally, M.D., Ph.D., Board member
Elizabeth McNally, M.D., Ph.D.
Board member since 2025
Ana de Pro Gonzalo, Board member
Ana de Pro Gonzalo
Board member since 2022
John D. Young, Board member
John D. Young
Board member since 2023
Charlotte Pamer-Wieser, Ph.D., Corporate secretary
Charlotte Pamer-Wieser, Ph.D.
Corporate Secretary since 2011